Early identification and treatment of Alzheimer's disease need the use of trustworthy and cost-effective screening technology. Researchers at Sweden's Karolinska Institutet discovered that the quantity of tau, a protein that plays an important role in the development of severe dementia, is linked to a kind of sugar molecule in the blood.
Early detection and treatment of Alzheimer's disease require the use of dependable and cost-effective screening technologies. Researchers at Sweden's Karolinska Institutet have revealed that the level of tau, a protein that plays a vital role in the development of severe dementia, is associated with a kind of sugar molecule in the blood.